AI-driven medical diagnosis service developer Beijing Shukun Network Co., Ltd has announced that it has secured 200 million yuan ($28 million) in its Series B1 round of financing led by BOC International Holdings Limited, a state-owned investment bank.
CCB International’s joint fund Jianxing Medical Fund participated in the latest round, which was also joined by existing investors Huagai Capital and CCV.
The company will use the proceeds to develop smart detection capability for the nervous system, oncology and heart diseases.
Headquartered in Beijing, Shukun offers smart “scan to report” to help hospitals and clinics to maximize disease diagnosis efficiency management. It claims to have served over hundreds of leading hospitals including Peking Union Medical College Hospital, Beijing Friendship Hospital, The First Affiliated Hospital of Sun Yat-Sen University, among others.
Shukun closed 100 million yuan ($14 million) in its Series A round of funding from Morningside Venture Capital, Huagai Capital, Marathon Venture Partners, and Lightsilver Capital in July 2018.
CHINA DEAL MONITOR
DealStreetAsia has also put together a table listing out all prominent venture capital transactions in the Greater China region from June 11-15, 2020.
